HOME >> BIOLOGY >> NEWS
Leader in cancer treatment and prevention research honored

PHILADELPHIA David S. Alberts, M.D., Regents Professor of Medicine, Pharmacology, Nutritional Science, and Public Health at the University of Arizona College of Medicine, and Director of the Cancer Prevention and Control Program at the Arizona Cancer Center, Tucson, is the recipient of the 2004 American Association for Cancer Research (AACR)-Cancer Research and Prevention Foundation (CRPF) Award for Excellence in Cancer Prevention Research. He is among the first in cancer research to begin studying in the laboratory those basic chemical agents and nutrients with the potential to treat or prevent cancer, and then to take them through pharmacological development and on to clinical trials in patients.

"Dr. Alberts is a true pioneer in translational cancer prevention research," said Margaret Foti, Ph.D., M.D. (h.c.), AACR chief executive officer.

"His many contributions to the field have advanced cancer prevention from its earliest preclinical and clinical stages of drug development to definitive, randomized controlled trials. His laboratory and clinical research has emphasized the chemoprevention and treatment of such pervasive and potentially deadly diseases as breast, colon, ovarian, and skin cancer."

Beginning in the 1970s, Dr. Alberts conducted landmark studies on the analytical chemistry and pharmacokinetics of retinoids derived from Vitamin A. Results of clinical trials in more than 2,200 patients led to the finding that retinol is effective in preventing squamous cell skin cancer. Following this work, he developed a panel of biomarkers of skin carcinogenesis, including proliferating cell nuclear antigen (PCNA), p53, polyamine levels, and apoptosis. Together with his research group, the Chemoprevention of Skin Cancer Program Project, he developed topically administered chemopreventive agents that can be incorporated into sunscreens.

Dr. Alberts also published an important study which rejected the hypothesis that dietary supple
'"/>

Contact: Sheri Ozard
ozard@aacr.org
215-440-9300
American Association for Cancer Research
30-Sep-2004


Page: 1 2 3

Related biology news :

1. 20 scientists selected as Aldo Leopold Leadership Fellows
2. Dr. Gonsalves will receive ASPB Leadership in Science Public Service Award
3. National Laboratory, National Parks And Forests Leaders Seek To Share Resources
4. Aldo Leopold Leadership Program Selects First Cohort
5. Online Briefings At AAAS To Feature New Research On Oceans; Discussion With Leaders Of Large Hadron Collider And International Space Station
6. Angry Biotech Firms Are Blaming The Industry Leader For Bringing Modified Crops Into Disrepute
7. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
8. Chemical derived from vitamin-E shows early promise as cancer drug
9. New molecular link key to cellular proteins involved in cancer progression, other diseases
10. Phase II trials of second-generation antisense cancer drug planned following successful early study
11. Trial shows which brain cancer patients benefit from temozolomide

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2019)... (PRWEB) , ... April 24, 2019 , ... ... Human Services Secretary Alex Azar today, a broad collective of 62 individual scientists, ... the American Society of Gene & Cell Therapy (ASGCT), across industry and academia ...
(Date:4/25/2019)... Ohio (PRWEB) , ... April 25, 2019 , ... ... agents, as well as screening tools, has strengthened its commitment to meeting today’s ... be used in any application where inhibition of its targeted proteases is needed. ...
(Date:4/18/2019)... , ... April 18, 2019 , ... ... industry, today announced the launch of mSource® AI Contract Text Analysis. This contract ... of Medpricer customers’ supplier contracts, truly optimizing purchased services spend at record speed. ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... April 09, 2019 , ... The American Society of Gene ... Society's leadership team, including a new addition to the presidential line of succession, at ... to join the Society's leadership team for a three-year term (2019-2021). , All five ...
(Date:4/8/2019)... ... April 09, 2019 , ... ... non-profit research center Chan Zuckerberg Biohub (CZ Biohub) has chosen Geneious Biologics to ... is part of CZ Biohub’s efforts to establish new approaches to inform the ...
(Date:3/29/2019)... VIEW, Calif. (PRWEB) , ... March 28, 2019 ... ... achievement of development and testing milestones, CARB-X has proceeded with a second stage ... receive up to $1.7 million, which is on top of the $1.7 million ...
(Date:3/27/2019)... ... March 27, 2019 , ... Lachman is sponsoring the event ... Hotel Burlington Road, Dublin, Ireland. The executive team on site will be available to ... key tracks on the agenda this year. , Executives from Lachman participating at this ...
Breaking Biology Technology:
Cached News: